Literature DB >> 19190027

Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes.

A Xanthis1, A Hatzitolios, S Fidani, C Befani, G Giannakoulas, G Koliakos.   

Abstract

INTRODUCTION: Advanced glycation end products (AGEs) engagement of a monocyte surface receptor (RAGE) induces atherosclerosis. AGEs also act as CD36 ligands. We studied reactive oxygen species (ROS) and CD36 expression after siRNA inhibition of RAGE expression in human monocytes.
METHODS: We isolated monocytes from: a) 10 type 2 diabetics, and b) 5 age- and sex-matched healthy individuals. CD36 expression and ROS production were evaluated before and after RAGE knockdown.
RESULTS: After incubation of monocytes with AGE + bovine serum albumin (BSA), CD36 expression and intracellular ROS increased significantly in all groups. In RAGE-knockdown monocytes, AGE-induced CD36 expression and ROS generation were also significantly inhibited.
CONCLUSIONS: Blocking RAGE expression using siRNA in human monocytes led to a significant inhibition of CD36 expression and ROS production, suggesting a positive interaction between RAGE, CD36 expression and ROS generation in monocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190027     DOI: 10.1177/0003319708328569

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  10 in total

1.  Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells.

Authors:  Jie Zhu; Peng Wang; Zhimin Yu; Wei Lai; Yi Cao; Pinbo Huang; Qiaodong Xu; Menglei Yu; Junyao Xu; Zitong Huang; Bing Zeng
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

3.  Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.

Authors:  Lilu Guo; Zhongyi Chen; Venkataraman Amarnath; Patricia G Yancey; Brian J Van Lenten; Justin R Savage; Sergio Fazio; MacRae F Linton; Sean S Davies
Journal:  Antioxid Redox Signal       Date:  2015-03-18       Impact factor: 8.401

Review 4.  Role of AGEs in the progression and regression of atherosclerotic plaques.

Authors:  Zhong-Qun Wang; Le-le Jing; Jin-Chuan Yan; Zhen Sun; Zheng-Yang Bao; Chen Shao; Qi-Wen Pang; Yue Geng; Li-Li Zhang; Li-Hua Li
Journal:  Glycoconj J       Date:  2018-07-10       Impact factor: 2.916

Review 5.  The RAGE/multiligand axis: a new actor in tumor biology.

Authors:  Armando Rojas; Ivan Schneider; Cristian Lindner; Ileana Gonzalez; Miguel A Morales
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

Review 6.  22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.

Authors:  Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-09       Impact factor: 8.311

7.  RAGE expression in human T cells: a link between environmental factors and adaptive immune responses.

Authors:  Eitan M Akirav; Paula Preston-Hurlburt; Justin Garyu; Octavian Henegariu; Raphael Clynes; Ann Marie Schmidt; Kevan C Herold
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

8.  Insights into binding of S100 proteins to scavenger receptors: class B scavenger receptor CD36 binds S100A12 with high affinity.

Authors:  Christoph Tondera; Markus Laube; Jens Pietzsch
Journal:  Amino Acids       Date:  2016-10-12       Impact factor: 3.520

Review 9.  The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury.

Authors:  Xiaoyun Gou; Junjie Ying; Yan Yue; Xia Qiu; Peng Hu; Yi Qu; Jinhui Li; Dezhi Mu
Journal:  Front Cell Neurosci       Date:  2020-12-15       Impact factor: 5.505

Review 10.  Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.

Authors:  Kiyoshi Kikuchi; Salunya Tancharoen; Takashi Ito; Yoko Morimoto-Yamashita; Naoki Miura; Ko-ichi Kawahara; Ikuro Maruyama; Yoshinaka Murai; Eiichiro Tanaka
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.